| NCT00136435 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Queen Elizabeth II Health Sciences Centre | Acute Lymphoblastic Leukemia | 2002-06 | PHASE2 |
| NCT00161239 | University of Medicine and Dentistry of New Jersey|Ortho Biotech, Inc. | T-Cell Lymphoma | 2005-02 | NA |
| NCT00610883 | Memorial Sloan Kettering Cancer Center | Non-Hodgkin´s Lymphoma | 1990-05 | PHASE2 |
| NCT01953770 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Childhood Acute Lymphoblastic Leukemia | 2008-02 | NA |
| NCT01225874 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1999-12 | NA |
| NCT03079544 | Rong Tao | Extranodal NK-T-Cell Lymphoma, Nasal Type | 2017-03-08 | |
| NCT00187005 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia | 1998-07 | PHASE3 |
| NCT01910428 | ERYtech Pharma | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2013-10 | PHASE1 |
| NCT00526305 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2000-01 | PHASE4 |
| NCT02036489 | PETHEMA Foundation | Acute Lymphobkastic Leukemia | 2008-01 | PHASE4 |
| NCT00131027 | Japan Adult Leukemia Study Group | Lymphoblastic Leukemia, Acute | 2002-09 | PHASE3 |
| NCT01518517 | ERYtech Pharma | Acute Lymphoblastic Leukemia, in Relapse | 2009-12 | PHASE2|PHASE3 |
| NCT04440267 | Institute of Hematology & Blood Diseases Hospital, China | Acute Leukemia of Ambiguous Lineage | 2020-07-08 | PHASE2 |
| NCT00186875 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia|Lymphoma, Lymphoblastic | 2003-11 | PHASE2 |
| NCT03623087 | The University of Hong Kong | Non-Hodgkin´s Lymphoma, Relapsed|Non-Hodgkin T-cell Lymphoma|Natural Killer+T-Cell Lymphoma, Nasal and Nasal-Type | 2017-07-01 | PHASE3 |
| NCT02419755 | St. Jude Children´s Research Hospital | Mixed Lineage Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoid Leukemia | 2015-04-14 | PHASE2 |
| NCT03286634 | National Hospital Organization Nagoya Medical Center | Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer | 2017-04-18 | PHASE2 |
| NCT00136084 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI) | Leukemia, Myelocytic, Acute | 2002-08 | PHASE3 |
| NCT02197650 | ERYtech Pharma | Acute Lymphoblastic Leukemia | | |
| NCT00187122 | St. Jude Children´s Research Hospital | Lymphoblastic Lymphoma | 1993-03 | NA |
| NCT01358253 | Ruijin Hospital | Acute Lymphoblastic Leukemia | 2010-12 | PHASE4 |
| NCT00873093 | National Cancer Institute (NCI) | B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia | 2009-03 | PHASE2 |
| NCT00526409 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2005-06 | PHASE4 |
| NCT00590915 | Phoenix Children´s Hospital|Fisher Bioservices|Jazz Pharmaceuticals | Leukemia, Acute Lymphoblastic|Acute Lymphoid Leukemia | | |
| NCT00187057 | St. Jude Children´s Research Hospital|Children´s Hospital of Philadelphia|National Cancer Institute (NCI) | Ataxia-Telangiectasia | 2002-09 | NA |
| NCT00549848 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI)|Enzon Pharmaceuticals, Inc.|National Institute of General Medical Sciences (NIGMS) | Acute Lymphoblastic Leukemia | 2007-10-29 | PHASE3 |
| NCT02894645 | National University Hospital, Singapore | Acute Lymphoblastic Leukemia (ALL) | 2008-10 | PHASE4 |
| NCT02544425 | Samsung Medical Center | Extranodal NK-T-Cell Lymphoma | 2016-02-21 | PHASE2 |
| NCT06099366 | Hee Young Ju|Asan Medical Center|Seoul National University Hospital|Seoul St. Mary´s Hospital|Severance Hospital|Pusan National University Yangsan Hospital|Korea University Anam Hospital|Chonnam National University Hospital|Jeju National University Hospital | Lymphoblastic Leukemia in Children | 2024-03-05 | PHASE2 |
| NCT00854425 | Fudan University | Lymphoma | 2008-06 | PHASE2 |
| NCT00526175 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2001-06 | PHASE4 |
| NCT00131053 | Japan Adult Leukemia Study Group | Lymphoblastic Leukemia, Acute | 2002-09 | PHASE2 |
| NCT00098839 | Children´s Oncology Group|National Cancer Institute (NCI) | Recurrent Childhood Acute Lymphoblastic Leukemia | 2005-02 | PHASE1|PHASE2 |
| NCT06336395 | National University Hospital, Singapore | B Lymphoblastic Leukemia | 2020-03-04 | PHASE2 |
| NCT00176462 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) | Acute Lymphocytic Leukemia | 2001-02 | PHASE2 |
| NCT03150693 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia | 2017-09-20 | PHASE3 |
| NCT00137111 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI) | Lymphoblastic Leukemia, Acute | 2000-07-08 | PHASE3 |